A detailed history of Cerity Partners LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cerity Partners LLC holds 198,433 shares of EW stock, worth $13 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
198,433
Previous 211,950 6.38%
Holding current value
$13 Million
Previous $20.3 Million 9.5%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $1.14 Million - $1.27 Million
-13,517 Reduced 6.38%
198,433 $18.3 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $12.2 Million - $16.1 Million
-168,074 Reduced 44.23%
211,950 $20.3 Million
Q4 2023

Jan 26, 2024

SELL
$61.71 - $77.76 $871,406 - $1.1 Million
-14,121 Reduced 3.58%
380,024 $29 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $3.68 Million - $4.96 Million
-53,072 Reduced 11.87%
394,145 $27.3 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $21.1 Million - $24.4 Million
259,097 Added 137.73%
447,217 $42.2 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $14 Million - $15.9 Million
188,120 New
188,120 $15.6 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $3.08 Million - $4.57 Million
35,604 New
35,604 $3.39 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $3.86 Million - $4.74 Million
-36,300 Closed
0 $0
Q3 2021

Oct 25, 2021

SELL
$102.91 - $122.75 $3,190 - $3,805
-31 Reduced 0.09%
36,300 $4.11 Million
Q2 2021

Aug 11, 2021

BUY
$83.84 - $104.76 $87,277 - $109,055
1,041 Added 2.95%
36,331 $3.76 Million
Q1 2021

Aug 11, 2021

BUY
$78.68 - $90.67 $1,967 - $2,266
25 Added 0.07%
35,290 $2.95 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $47,522 - $54,764
-604 Reduced 1.68%
35,265 $2.95 Million
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $193,993 - $246,868
-2,706 Reduced 7.01%
35,869 $3.27 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $263,855 - $343,376
3,927 Added 11.33%
38,575 $3.08 Million
Q2 2020

Aug 17, 2020

SELL
$57.54 - $76.95 $6,502 - $8,695
-113 Reduced 0.33%
34,648 $2.4 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $1.34 Million - $1.79 Million
23,240 Added 201.72%
34,761 $2.4 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $29,559 - $45,684
-564 Reduced 4.67%
11,521 $2.17 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $24,378 - $27,910
340 Added 2.89%
12,085 $2.82 Million
Q3 2019

Oct 30, 2019

BUY
$61.55 - $75.43 $13,479 - $16,519
219 Added 1.9%
11,745 $2.58 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $61,481 - $71,044
-1,103 Reduced 8.73%
11,526 $2.13 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $1,724 - $2,305
-36 Reduced 0.28%
12,629 $2.42 Million
Q4 2018

Feb 06, 2019

SELL
$46.41 - $56.94 $57,873 - $71,004
-1,247 Reduced 8.96%
12,665 $1.94 Million
Q3 2018

Nov 15, 2018

BUY
$45.7 - $58.03 $34,137 - $43,348
747 Added 5.67%
13,912 $2.42 Million
Q2 2018

Aug 15, 2018

BUY
$42.45 - $51.3 $3,947 - $4,770
93 Added 0.71%
13,165 $1.92 Million
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $486,147 - $620,266
13,072 New
13,072 $1.82 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $462,686 - $539,367
-13,693 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $496,918 - $531,699
13,693
13,693 $1.5 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.